VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 703 filers reported holding VANECK VECTORS ETF TR in Q2 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,058,858 | -18.0% | 76,509 | -8.3% | 0.01% | -7.1% |
| Q2 2023 | $2,511,175 | -24.5% | 83,400 | -18.8% | 0.01% | -26.3% |
| Q1 2023 | $3,324,602 | +11.7% | 102,770 | -1.0% | 0.02% | +11.8% |
| Q4 2022 | $2,975,302 | +15.8% | 103,814 | -2.5% | 0.02% | +13.3% |
| Q3 2022 | $2,569,000 | -16.9% | 106,504 | -5.7% | 0.02% | -11.8% |
| Q2 2022 | $3,092,000 | -31.0% | 112,920 | -3.3% | 0.02% | -22.7% |
| Q1 2022 | $4,480,000 | +18.5% | 116,814 | -1.0% | 0.02% | +29.4% |
| Q4 2021 | $3,781,000 | +4.2% | 118,033 | -4.2% | 0.02% | -5.6% |
| Q3 2021 | $3,630,000 | -12.1% | 123,166 | +1.4% | 0.02% | -14.3% |
| Q2 2021 | $4,129,000 | -5.3% | 121,510 | -9.4% | 0.02% | -12.5% |
| Q1 2021 | $4,360,000 | -4.9% | 134,167 | +5.4% | 0.02% | -14.3% |
| Q4 2020 | $4,586,000 | -4.4% | 127,320 | +3.9% | 0.03% | -9.7% |
| Q3 2020 | $4,799,000 | +30.9% | 122,536 | +22.6% | 0.03% | +14.8% |
| Q2 2020 | $3,667,000 | +82.4% | 99,983 | +14.6% | 0.03% | +58.8% |
| Q1 2020 | $2,010,000 | +26.7% | 87,235 | +61.0% | 0.02% | +70.0% |
| Q4 2019 | $1,586,000 | +33.5% | 54,168 | +21.8% | 0.01% | +25.0% |
| Q3 2019 | $1,188,000 | +32.1% | 44,480 | +26.4% | 0.01% | +33.3% |
| Q2 2019 | $899,000 | +114.0% | 35,185 | +87.9% | 0.01% | +100.0% |
| Q1 2019 | $420,000 | +8.2% | 18,725 | +1.7% | 0.00% | 0.0% |
| Q4 2018 | $388,000 | +17.6% | 18,405 | +3.4% | 0.00% | +50.0% |
| Q3 2018 | $330,000 | -21.1% | 17,804 | -5.0% | 0.00% | -33.3% |
| Q2 2018 | $418,000 | -14.7% | 18,736 | -15.9% | 0.00% | -25.0% |
| Q1 2018 | $490,000 | -5.0% | 22,288 | +0.4% | 0.00% | 0.0% |
| Q4 2017 | $516,000 | -3.9% | 22,195 | -5.0% | 0.00% | -20.0% |
| Q3 2017 | $537,000 | +6.8% | 23,370 | +2.5% | 0.01% | 0.0% |
| Q2 2017 | $503,000 | -6.7% | 22,801 | -3.6% | 0.01% | 0.0% |
| Q1 2017 | $539,000 | -10.3% | 23,644 | -17.7% | 0.01% | -16.7% |
| Q4 2016 | $601,000 | -88.7% | 28,732 | -85.8% | 0.01% | -88.5% |
| Q3 2016 | $5,342,000 | -54.8% | 202,102 | -52.1% | 0.05% | -56.7% |
| Q2 2016 | $11,821,000 | – | 422,162 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |